Basic info
Industry
biotechnology research
Sectors
Biotechnology
Cancer Treatment
Life Science
Patient Friendly Therapies
Biotech
Irreversible Inhibitors
Liquid Tumors
Acute Myeloid Leukemia
Innovative Medicine
Oncology
Solid Tumors
Targeted Medicine
Therapeutics
Diabetes Mellitus
Novel Mechanism of Action
Menin
MLL Fusion
Date founded
2017
Funding rounds raised
Total raised
$56M
from 3 investors over 3 rounds
B
Biomea Fusion raised $56M on January 6, 2021
Investors: Aisling Capital, RTW Investments, LP and Logos Global Management, LP